Latest news

02 March 2023

Access European Urology Today: EAU23 Congress Edition

16 February 2023

Videos: Hints and tricks for presenters

If you’re presenting an abstract at EAU23, why not prepare yourself with these three short videos by our expert on
23 January 2023

Dive back into learning: Join EAU23’s dynamic mix of educational activities

Optimal learning involves more than active listening. Enjoy and benefit from a well-rounded (and fun) educational experience at EAU23. Expect
15 January 2023

Get crucial updates and skills-building on patient engagement

The EAU Patient Office is currently preparing for its major annual event, the EAU Patient Day. Since its inception, the
12 January 2023

A new approach to Live Surgery at EAU23

There will be a new approach to live surgery at EAU23, as the Scientific Congress Office is more directly involved
10 January 2023

What’s on the agenda for young urologists at EAU23?

There is a fascinating programme planned for this year’s edition of YUORDay which will take place on Saturday, 11 March
15 December 2022

EAU23: The Big Scientific Programme Preview

On 10-13 March 2023, Milan will host one of the world’s largest urology events. Over 4500 abstracts were submitted for
25 November 2022

EAU23: Abstract submission numbers for Milan back to normal

Submissions came in from all over the world After two years of lower abstract submission numbers, it looks like the
22 November 2022

History Congress to offer “inspiration and perspective”

The EAU History Office is hosting another edition of the International Congress on the History of Urology to coincide with
10 July 2022

Liquid biomarkers: What do we expect in the future?

Chaired by Prof. Lars Dyrskjøt (DK) and Prof. Arnulf Stenzl (DE), Plenary Session 7 was full of rapid-fire debate reviewing
04 July 2022

Liquid Biomarkers in oncology

04 July 2022

EAUTV: The role of lasers in Stone treatment

04 July 2022

All facets of stone surgery covered at Plenary Session 8

Current cystinuria research is focused on methods of monitoring disease activity, as well as novel drug therapies and genotype-phenotype studies.